AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS
Pagina dedicata companiei AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS listata cu simbolul US.AVDL
Descriere companie[edit | ]
Avadel Pharmaceuticals plc (www.avadel.com) is a biopharmaceutical company. The Company’s lead product candidate, FT218, is an investigational once-nightly formulation of sodium oxybate for the treatment of excessive daytime sleepiness (EDS), and cataplexy in narcolepsy patients. Its Micropump allows for the development of modified and/or controlled release solid, oral dosage formulations of drugs. Its LiquiTime technology allows for development of modified/controlled release oral products in a liquid suspension formulation, which may make such formulations particularly suited for children and/or patients having issues swallowing tablets or capsules. Its Medusa technology allows for the development of extended-/modified-release injectable dosage formulations of drugs.
Grafic actiuni companie[edit | ]